
Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Fax+1 216-444-9774
Dr. Bolwell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1984 - 1987
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1981 - 1984
Case Western Reserve University School of MedicineClass of 1981
Harvard UniversityB.A., 1977
Certifications & Licensure
OH State Medical License 1981 - 2027
PA State Medical License 1984 - 1996
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- 14 citationsClonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic
Leukemia. 2024-06-01 - 3 citationsAuthentic leadership at the Cleveland Clinic: psychological safety in the midst of crisis.Tracy Hopkins Porter, Jessica A Peck, Brian Bolwell, James K Stoller
BMJ Leader. 2023-01-13 - 3 citationsInfluence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.Sanghee Hong, Lisa Rybicki, Aiwen Zhang, Dawn Thomas, Cassandra M Kerr
Transplantation and Cellular Therapy. 2021-08-08
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
Abstracts/Posters
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Brian J. Bolwell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 2012 Highlights of ASH in North America (San Francisco, CA)American Society of Hematology (ASH), San Francisco, California - 2/3/2012
Press Mentions
President Biden’s Cabinet Members Confirmed, HVO Presents Golden Apple Awards, and MoreMay 1st, 2021
Cleveland Clinic Names Dr. Brian Bolwell to New Physician Leadership RoleApril 8th, 2021
How US News' Best Hospitals for Cancer Care Are Improving Patient OutcomesSeptember 8th, 2020
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
